Bridge IV Solutions Product Training
Product-level training on Bridge 0.9% Sodium Chloride IV solutions in Fleboflex containers. Covers formulation, PVC-free container technology, compatibility, administration, and safety.
Bridge IV Solutions — Product Overview
Bridge partners with Grifols — a global healthcare leader — to supply 0.9% Sodium Chloride Injection, USP in the Fleboflex polypropylene container system. This module provides a foundational overview of the product, its indications, and why it represents the standard for non-acute IV infusion settings.
Fleboflex Container Technology & Design
The Fleboflex container represents a significant advancement over traditional PVC IV bags. Understanding its material science and design features helps clinicians appreciate why it is the preferred choice for modern outpatient infusion settings.
Why PVC-Free Matters — Clinical Advantages
Traditional IV bags are made from polyvinyl chloride (PVC) that requires plasticizers — most commonly DEHP (di-2-ethylhexyl phthalate) — to achieve flexibility. DEHP can leach from the bag into the IV solution, particularly when lipophilic drugs are infused or when the bag is exposed to heat or extended storage. Fleboflex eliminates this concern entirely.
Drug Compatibility & Admixture Guidelines
Fleboflex containers have undergone extensive drug-container compatibility studies conducted by Grifols. These studies confirm stability and compatibility with a selected number of commonly used drug admixtures, making Fleboflex suitable for compounding in wellness and outpatient settings.
Preparation & Administration — Bridge Protocol
This module covers the step-by-step Bridge protocol for preparing and administering 0.9% Sodium Chloride from the Fleboflex container system. Following these steps ensures sterility, safety, and compliance with FDA-labeled directions for use.
Adding Medications to Fleboflex Containers
Fleboflex containers feature a resealable medication port designed for safe additive injection. This module covers the correct technique for adding medications both before and during infusion administration.
Important Safety Information & Warnings
This module covers the critical safety information, warnings, and precautions for 0.9% Sodium Chloride Injection, USP as required by the FDA prescribing information. All Bridge clinicians must be familiar with these warnings.
Storage, Handling & Supply Specifications
Proper storage and handling of IV solutions is critical to maintaining product integrity, sterility, and patient safety. This module covers the Bridge-recommended protocols for receiving, storing, and inventorying Fleboflex IV solutions.